Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pseudoalteromone A, a Ubiquinone Derivative from Marine Pseudoalteromonas spp., Suppresses Melanogenesis. | Mar Drugs | 2021 | 34822483 | PubTator, text mining | PubMed |
| CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders. | Theranostics | 2021 | 34815795 | PubTator, text mining | PubMed |
| La transplantation pulmonaire dans le contexte de la COVID-19 aiguë : l’expérience du Programme de transplantation pulmonaire de Toronto. | CMAJ | 2021 | 34810168 | PubTator, text mining | PubMed |
| Localized Amyloidosis of the Nasal Mucosa: A Case Report and Review of the Literature. | Front Surg | 2021 | 34805263 | PubTator, text mining | PubMed |
| Anti-melanogenic property of ginsenoside Rf from Panax ginseng via inhibition of CREB/MITF pathway in melanocytes and ex vivo human skin. | J Ginseng Res | 2021 | 34803425 | PubTator, text mining | PubMed |
| Cell type identification from single-cell transcriptomes in melanoma. | BMC Med Genomics | 2021 | 34784909 | PubTator, text mining | PubMed |
| Modeling of endothelial cell dysfunction using human induced pluripotent stem cells derived from patients with end-stage renal disease. | Kidney Res Clin Pract | 2021 | 34781643 | PubTator, text mining | PubMed |
| Study on the bZIP-Type Transcription Factors NapA and RsmA in the Regulation of Intracellular Reactive Species Levels and Sterigmatocystin Production of Aspergillus nidulans. | Int J Mol Sci | 2021 | 34769008 | PubTator, text mining | PubMed |
| Extracellular vesicles released by human retinal pigment epithelium mediate increased polarised secretion of drusen proteins in response to AMD stressors. | J Extracell Vesicles | 2021 | 34750957 | PubTator, text mining | PubMed |
| The Formation of Melanocyte Apoptotic Bodies in Vitiligo and the Relocation of Vitiligo Autoantigens under Oxidative Stress. | Oxid Med Cell Longev | 2021 | 34745423 | PubTator, text mining | PubMed |
| Influence of Fruit and Vegetable Consumption on Antioxidant Status and Semen Quality: A Cross-Sectional Study in Adult Men. | Front Nutr | 2021 | 34722613 | PubTator, text mining | PubMed |
| New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation. | Front Oncol | 2021 | 34722301 | PubTator, text mining | PubMed |
| Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism. | Front Genet | 2021 | 34707637 | PubTator, text mining | PubMed |
| mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients. | Vaccines (Basel) | 2021 | 34696168 | PubTator, text mining | PubMed |
| Wound Healing-Promoting and Melanogenesis-Inhibiting Activities of Angelica polymorpha Maxim. Flower Absolute In Vitro and Its Chemical Composition. | Molecules | 2021 | 34684753 | PubTator, text mining | PubMed |
| Sargahydroquinoic Acid Suppresses Hyperpigmentation by cAMP and ERK1/2-Mediated Downregulation of MITF in α-MSH-Stimulated B16F10 Cells. | Foods | 2021 | 34681303 | PubTator, text mining | PubMed |
| Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis. | Genes (Basel) | 2021 | 34680938 | PubTator, text mining | PubMed |
| New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review. | Biomedicines | 2021 | 34680428 | PubTator, text mining | PubMed |
| Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells. | Cancer Cell | 2021 | 34678150 | PubTator, text mining | PubMed |
| Trial watch: intratumoral immunotherapy. | Oncoimmunology | 2021 | 34676147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=42